atheroma

(redirected from Atherosclerotic plaque)
Also found in: Dictionary, Thesaurus, Medical.

atheroma

[‚ath·ə′rōm·ə]
(medicine)
A lipid deposit in the inner wall of an artery; characteristic of atherosclerosis.
Mentioned in ?
References in periodicals archive ?
Furthermore, the physical state of collagen can have a great impact on the development of atherosclerotic plaque by interfering with SMCs and macrophages [7, 8].
pylori infection in coronary atherosclerotic plaques and carotid plaques using molecular method and assess the probability of the infection on development of coronary artery disease.
Comparison of iodinated contrast media for the assessment of atherosclerotic plaque attenuation values by CT coronary angiography: observations in an ex vivo model.
The adventitia, media, and the atherosclerotic plaques of the coronary and carotid arteries have their own nutrition supply: the vasa vasorum, a network of small microvessels.
Sata, "Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice," Atherosclerosis, vol.
Bouhlel et al., "Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPAR[gamma] and LXR[alpha] pathways," Circulation Research, vol.
miRNAs in the atherosclerotic plaque: a summary of the expression of the vascular biology-associated miRNAs discussed in this review in atherosclerotic plaques found in the TVS.
(34) Diabetes mellitus/ hyperglycemia-induced oxidative stress/reactive oxygen species is one of the factors that can promote both vascular smooth muscle cell proliferation/migration in atherosclerotic lesions and vascular smooth muscle cell apoptosis, which results in atherosclerotic plaque instability and rupture.
In a series of studies, it was subsequently shown that this type of [CD4.sup.+] T cells is present in unstable atherosclerotic plaques and associated with an increased risk for recurrence of both acute coronary events and ischemic stroke [11-15].
"A reasonable policy may be to promote a greater awareness of LDL cholesterol levels and a new emphasis on diet and lifestyle to keep LDL low, and in those persons in their 20s who can't maintain ideal levels of cholesterol--somewhere between 50 and 70 mg/dL--it may be reasonable at that time to begin contemplating adding medication to prevent the development of atherosclerotic plaque," explained Dr.
AtheroNova Inc., through its wholly-owned subsidiary, AtheroNova Operations, Inc., is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.
Angiograms demonstrated stenosis of proximal segment (85%) of right internal carotid artery with signs of the atherosclerotic plaque ulceration (Figure 1a).

Full browser ?